IOLCP Announces Special Window for Physical Share Transfer & KYC Update Campaign
IOLCP announces a Special Window for physical share transfer-cum-dematerialisation for shares with transfer deeds executed before April 1, 2019. It also promotes the 'Saksham Niveshak' campaign (April 1 to July 9, 2026) for claiming unclaimed dividends and updating KYC. Contact Alankit Assignments Limited for details.
The announcement concerns procedural matters for shareholders related to physical share transfers and unclaimed dividends. It does not involve any new business initiatives, financial results, or corporate actions that would have a significant immediate impact on the company's operations or stock price.
The announcement is a routine regulatory filing regarding a special window for share transfers and a campaign for unclaimed dividends and KYC updates. It does not contain any financial performance data or strategic business updates that would significantly alter the company's outlook.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has submitted copies of newspaper publications regarding a Special Window for the Transfer-cum-Dematerialisation of Physical Shares. This initiative, launched pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/V3750/2026 dated 30th January 2026, aims to assist shareholders in transferring physical shares where the transfer deed was executed prior to 1st April 2019, including cases with previous transfer request issues.
Additionally, the company is participating in the Investor Education and Protection Fund Authority's (IEPFA) 'Saksham Niveshak' - Second 100 Days Campaign, running from 1st April 2026 to 9th July 2026. This campaign encourages shareholders to claim unpaid/unclaimed dividends and update their KYC details to prevent shares and dividends from being transferred to the IEPF.
Shareholders can contact the Company's Registrar and Share Transfer Agent, Alankit Assignments Limited, for detailed guidelines, forms, and procedures. The newspaper publication was made on 19th June 2026 in Financial Express (English) and Punjabi Jagran (Punjabi).
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.